Delphia Therapeutics

www.delphiatx.com
1400 One Kendall Square Suite 14-302
Cambridge, MA 02139

Company Info

Year Established
2022

Contacts

Kevin Marks, Ph.D.
President & CEO

Company Description

Delphia Therapeutics is pioneering an entirely new field of cancer biology – activation lethality – to advance a new treatment paradigm and improve the lives of cancer patients.